MedRhythms
medrhythms.com
Actively hiring
Patient Monitoring
Neurotech & Neuromodulation
As featured in
View 1 job
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$54.2M
9 rounds on record
Latest round
$3.3M
Venture round · Feb 2026 · 8 mo ago
Team
43
US Form 5500 (plan participants) · Dec 2025 · +26% in a year
Hiring now
6
open roles
Backers
1
Global Brain
The money's age
Fresh money
8 months since the last round · hiring slowed
Momentum
30/100
a new city, fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2
Took on debt financing $250k · SEC Form D
Aug 7
Board appointment Musan Duric, Director · SEC Form D
Jul 31
Took on debt financing $1M · SEC Form D
Feb 13
Raised a round Venture round $3.3M · SEC Form D
2025
Team of 43 was 34 · US Form 5500 (plan participants)
Apr 2, 2025
Launched MedRhythms Announces Availability of Movive for Parkinson · PRNewswire
Mar 28, 2025
Took on debt financing $2.9M · SEC Form D
Nov 27, 2023
Raised a round Venture round $19.8M · SEC Form D
Feb 8, 2023
Took on debt financing $5.8M · SEC Form D
May 5, 2022
Partnership MedRhythms partners with Biogen to develop, commercialize mobility PDT · mobihealthnews.com
Jul 28, 2021
Raised a round Series B $25M · YahooFinance
May 19, 2021
Partnership MedRhythms and EVERSANA announce partnership to launch and commercialize chronic stroke software-based medical device · markets.businessinsider.com
Aug 8, 2019
Raised a round Venture round $1.5M · SEC Form D
Jun 27, 2018
Raised a round Venture round $4.7M · SEC Form D
2013
Founded
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Debt Financing | Oct 2026 | $250k | — | SEC Form D |
| Debt Financing | Jul 2026 | $1M | — | SEC Form D |
| Venture round | Feb 2026 | $3.3M | — | SEC Form D |
| Debt Financing | Mar 2025 | $2.9M | — | SEC Form D |
| Venture round | Nov 2023 | $19.8M | — | SEC Form D |
| Debt Financing | Feb 2023 | $5.8M | — | SEC Form D |
| Series B | Jul 2021 | $25M | — | YahooFinance |
| Venture round | Aug 2019 | $1.5M | — | SEC Form D |
| Venture round | Jun 2018 | $4.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | MedRhythms, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Brian HarrisExecutive Officer, DirectorSEC Form D
Owen McCarthyExecutive Officer, DirectorSEC Form D
Lawrence JasinskiExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Global Brain Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
SceneRay is a Chinese medical device company that develops, manufactures and sells deep brain stimulation systems with its own intellectual…
Explore Nervonik neuromodulation devices that are working to redefine peripheral nerve stimulation with advanced technology for high motion.
Mendea. We are a UK startup building non-invasive ultrasound brain stimulation technology.
Paragit Solutions is an early-stage medical device startup working to develop and market a novel solution to support early diagnosis and…
Acurable is a venture-backed, fast growing, medical devices company, with offices in London and Seville. We create accurate, but very…
Neurosom™ is a company established to develop medical devices and therapeutic protocols for improving sleep through both psychological…
How MedRhythms hires
Truth index
B 75/100
Ghost roles
0%
Stale roles
100%
Reposted roles
0%
MedRhythms scores B on the Alion truth index (A is best, E worst), measured over 6 open roles re-checked against its own hiring board: 0% look like ghost listings, 100% have gone stale and 0% are the same role posted again. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
News
MedRhythms and Edwards Health Care Services, a GEMCORE Family Company, Enter into National Distribution Agreement
/PRNewswire/ -- MedRhythms, Inc., a leader in neurologic and physical rehabilitation with the world
Read more
Report
MedRhythms Co-Founder and Chief Scientific Officer, Brian Harris, Named 2025 Fellow of the American Congress of Rehabilitation Medicine (ACRM)
/PRNewswire/ -- MedRhythms, Inc., a leader in neurologic and physical rehabilitation with the world
Read more
Report
MedRhythms Announces Availability of Movive for Parkinson
/PRNewswire/ -- MedRhythms today announced that Movive, the company
Read more
Report
MedRhythms Announces FDA Class II Listing for Movive to Support Gait Rehabilitation and Motor Function for Parkinson
/PRNewswire/ -- MedRhythms today announced that MR-005, the company
Read more
Report
MedRhythms Announces New CMS Reimbursement Code for InTandem Rehabilitation System For Chronic Stroke Gait Impairment
/PRNewswire/ -- MedRhythms, Inc. today announced that the Centers for Medicare and Medicaid Services (CMS) established a new reimbursement code for the...
Read more
Report
MedRhythms Announces Key Publications Confirming Efficacy, Safety, and Usability of InTandem for Chronic Stroke Walking Impairment
/PRNewswire/ -- MedRhythms announced today publication of two studies validating the efficacy, safety, and usability of InTandem, a FDA-authorized,...
Read more
Report
MedRhythms Announces FDA Listing of InTandem (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke
/PRNewswire/ -- MedRhythms today announced that MR-001, the company
Read more
Report
KOL Event on Next-Generation Neurotherapeutics: Leveraging the Power of Music and Technology
March 20, 2023 at 11:00 AM ET...
Read more
Report
MedRhythms Announces Positive Topline Results from Pivotal Trial in Chronic Stroke
/PRNewswire/ -- MedRhythms announced today that the company
Read more
Report
Hope Post-Stroke: Stories of Resilience and Determination from the Stroke Survivor Community
Every year, the stroke community comes together to celebrate two important months: Stroke Awareness Month and Aphasia Awareness Month. May is National Stroke Awareness Month, a time when the stroke community shares resources to help reduce stroke risk and
Read more
Report
Show more news
People
Brian Harris
Executive Officer, Director
Owen McCarthy
Executive Officer, Director
Lawrence Jasinski
Executive Officer, Director
Jean Hoffman
Director
Raymond Pawlicki
Director
Peter Werth
Director
Stephen Bruso
Director
Christopher Harris
Director
Ray Pawlicki
Director
Bill McKee
Director
William McKee
Director
Isaac Cheng
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
36/100
Slowing
Open positions
6
0 opened / 0 closed in 30 days
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
33% ▼
HR
17% ▼
Operations
17% ▼
Customer Success
17% ▼
Biotech
17% ▼
Activity Timeline
New location: Portland
Sep 2026
Added Microsoft Office to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
4
Hiring now
3
Countries
1
Busiest office
Portland
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Portland
United States
HQ
Portland
United States
Regional office
Cookie Policy
3 open roles 50-200 est. staff
hires for Operations, Customer Success, Biotech
183 Middle St, Portland, ME 04101
Boston
United States
1 open roles 50-200 est. staff
hires for Early Careers
White Plains
United States
1 open roles 50-200 est. staff
hires for Early Careers
Jobs
Apply
Financials
Total raised
$64.2M
Latest round
Debt Financing
Funding rounds
9
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Debt Financing | 2026 | $250k | Details |
| Debt Financing | 2026 | $1M | Details |
| Venture - Series Unknown | 2026 | $3.3M | Details |
| Debt Financing | 2025 | $2.9M | Details |
| Venture - Series Unknown | 2023 | $19.8M | Details |
| Debt Financing | 2023 | $5.8M | Details |
| Series B | 2021 | $25M | Details |
| Venture - Series Unknown | 2019 | $1.5M | Details |
| Venture - Series Unknown | 2018 | $4.7M | Details |